Moderna Covid Vaccine Trial
- All
- News
- Videos
-
Moderna's New Bivalent Omicron Jab Shows "Positive Results" In Trials
US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron.
-
Infant Covid Vaccine Succeeded In Trial, Says Moderna
US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
Fourth Covid Vaccine "Partially" Effective Against Omicron: Study
Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
Foreign Vaccines Like Pfizer, Moderna A Step Closer With Key India Waiver
In a big move to clear the way for foreign vaccines like Pfizer and Moderna, the drug regulator has done away with the requirement of India-specific trials.
-
Amid Pfizer Talks, Centre Reiterates Policy Change For Foreign Vaccines
The government stressed that it has scrapped local trials for "well-established" foreign vaccines to fast-track imports, soon after Pfizer said it is ready to offer five crore doses this year but sought relaxations including indemnity from liability.
-
Moderna Says Covid Vaccine "Highly Effective" In Adolescents
US biotech firm Moderna said Tuesday that trials had shown its Covid-19 vaccine is "highly effective" in adolescents aged 12-17 and the company would seek regulators' approval in June.
-
Told India No Safety Concerns With Covid Vaccine, Says Pfizer
Pfizer said on Monday it told the Indian government that there was no concern over the safety of its COVID-19 vaccine, as India insists on small local trials for foreign shots despite a record surge in infections and shortage of doses.
-
Moderna Announces Start Of Covid Vaccine Trials For Children
US manufacturer Moderna on Tuesday said it has started Covid-19 vaccine trials for children aged from 6 months to under 12 years old, with plans to enroll about 6,750 participants.
-
When And How Will COVID-19 Vaccines Become Available Around The World
Pfizer Inc with partner BioNTech SE and Moderna Inc have released trial data showing their COVID-19 vaccines to be about 95 per cent effective at preventing the illness, while AstraZeneca Plc this week said its vaccine could be up to 90 per cent effective.
-
Pfizer, Moderna Boost Hopes But Many Nations Counting On Oxford Vaccine
Trial successes from Pfizer Inc. and Moderna Inc. have buoyed hopes that a Covid-19 vaccine is coming soon. But much of the world, outside of rich nations like the U.S., is counting on another company's shot to escape the crisis.
-
Moderna Says Vaccine Stable At Refrigerator Temperatures For 30 Days
Moderna Inc. said its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial, another sign that a fast-paced hunt by scientists and pharmaceutical companies is paying off with potent new tools that could help control a worsening pandemic.
-
"Stunningly Impressive": Top US Expert On Moderna Covid Vaccine Results
The United States' top infectious disease scientist on Monday hailed early results from Moderna's Covid-19 vaccine trial as "stunningly impressive," calling the findings an emphatic validation of experimental mRNA technology that some had doubted.
-
UK Orders 5 Million Doses Of Moderna's Covid Vaccine Candidate
Britain has secured 5 million doses of an experimental COVID-19 vaccine developed by Moderna Inc after it reported positive trial results, health minister Matt Hancock said on Monday, with the earliest doses expected for delivery in spring.
-
Moderna's New Bivalent Omicron Jab Shows "Positive Results" In Trials
US biotech company Moderna on Wednesday announced positive results for a new vaccine that targets both the original Covid strain and Omicron.
-
Infant Covid Vaccine Succeeded In Trial, Says Moderna
US biotech firm Moderna on Wednesday said it was pursuing regulatory approval for its Covid vaccine in children aged six months to six years after the two-shot regimen was found to be safe and produced a strong immune response.
-
Moderna Begins Omicron-Specific Vaccine Trials After Pfizer-BioNTech
US biotech company Moderna announced on Wednesday that it has begun clinical trials of a booster dose of vaccine designed specifically to combat the Omicron variant of the coronavirus.
-
Fourth Covid Vaccine "Partially" Effective Against Omicron: Study
Fourth doses of the Pfizer and Moderna vaccines against Covid-19 are only "partially" effective for the Omicron variant of the virus, the authors of an Israeli trial said Monday.
-
Moderna Submits Application Before US Regulator For Covid Booster Shot
Moderna on Wednesday announced it had begun submitting an application to the US Food and Drug Administration to authorize a booster of its Covid vaccine after trial data showed a significant increase in antibodies against variants.
-
Foreign Vaccines Like Pfizer, Moderna A Step Closer With Key India Waiver
In a big move to clear the way for foreign vaccines like Pfizer and Moderna, the drug regulator has done away with the requirement of India-specific trials.
-
Amid Pfizer Talks, Centre Reiterates Policy Change For Foreign Vaccines
The government stressed that it has scrapped local trials for "well-established" foreign vaccines to fast-track imports, soon after Pfizer said it is ready to offer five crore doses this year but sought relaxations including indemnity from liability.
-
Moderna Says Covid Vaccine "Highly Effective" In Adolescents
US biotech firm Moderna said Tuesday that trials had shown its Covid-19 vaccine is "highly effective" in adolescents aged 12-17 and the company would seek regulators' approval in June.
-
Told India No Safety Concerns With Covid Vaccine, Says Pfizer
Pfizer said on Monday it told the Indian government that there was no concern over the safety of its COVID-19 vaccine, as India insists on small local trials for foreign shots despite a record surge in infections and shortage of doses.
-
Moderna Announces Start Of Covid Vaccine Trials For Children
US manufacturer Moderna on Tuesday said it has started Covid-19 vaccine trials for children aged from 6 months to under 12 years old, with plans to enroll about 6,750 participants.
-
When And How Will COVID-19 Vaccines Become Available Around The World
Pfizer Inc with partner BioNTech SE and Moderna Inc have released trial data showing their COVID-19 vaccines to be about 95 per cent effective at preventing the illness, while AstraZeneca Plc this week said its vaccine could be up to 90 per cent effective.
-
Pfizer, Moderna Boost Hopes But Many Nations Counting On Oxford Vaccine
Trial successes from Pfizer Inc. and Moderna Inc. have buoyed hopes that a Covid-19 vaccine is coming soon. But much of the world, outside of rich nations like the U.S., is counting on another company's shot to escape the crisis.
-
Moderna Says Vaccine Stable At Refrigerator Temperatures For 30 Days
Moderna Inc. said its Covid-19 vaccine was 94.5% effective in a preliminary analysis of a large late-stage clinical trial, another sign that a fast-paced hunt by scientists and pharmaceutical companies is paying off with potent new tools that could help control a worsening pandemic.
-
"Stunningly Impressive": Top US Expert On Moderna Covid Vaccine Results
The United States' top infectious disease scientist on Monday hailed early results from Moderna's Covid-19 vaccine trial as "stunningly impressive," calling the findings an emphatic validation of experimental mRNA technology that some had doubted.
-
UK Orders 5 Million Doses Of Moderna's Covid Vaccine Candidate
Britain has secured 5 million doses of an experimental COVID-19 vaccine developed by Moderna Inc after it reported positive trial results, health minister Matt Hancock said on Monday, with the earliest doses expected for delivery in spring.
